Two cases of alopecia areata responsive to fexofenadine [5]

Journal of Dermatology

Volumn 34, Issue 12, 2007, Pages 852-854

  Inui, Shigeki ^a,b   Nakajima, Takeshi ^a   Itami, Satoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHARANTHINE; DIPHENCYPRONE; EBASTINE; FEXOFENADINE;

ADULT; AGED; ALOPECIA AREATA; ALOPECIA TOTALIS; CASE REPORT; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYEBROW; FEMALE; HUMAN; IMMUNOTHERAPY; LETTER; SCALP HAIR; TATTOO; TOPICAL TREATMENT; TREATMENT OUTCOME;

ADULT; AGED; ALOPECIA AREATA; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; TERFENADINE;

EID: 36849023851     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2007.00401.x     Document Type: Letter

References (13)

1. Gilhar A, Etzioni A, Assy B, Eidelman S. Response of grafts from patients with alopecia areata transplanted onto nude mice, to administration of interferon-γ. Clin Immunol Immunopathol 1993 66:120 126.
2. Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 2004 164:623 634.
3. Toyoda M, Makino T, Kagoura M, Morohashi M. Expression of neuropeptide-degrading enzymes in alopecia areata: an immunohistochemical study. Br J Dermatol 2001 144:46 54.
4. Giustizieri ML, Albanesi C, Fluhr J et al. H1 histamine receptor mediates inflammatory responses in human keratinocytes. J Allergy Clin Immunol 2004 114:1176 1182.
5. MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG, British Association of Dermatologists. Guidelines for the management of alopecia areata. Br J Dermatol 2003 149:692 699.
6. Ogawa H, Imai R, Nishiyama S et al. The effect of an anti-allergic drug on the disease activity of alopecia areata. Skin Res 1994 36:60 68 (in Japanese).
7. Ogawa H, Ueki R, Nishiyama S, Ito M, Nishioka K. The effect of an anti-allergic drug (azelastine) on alopecia areata, Nishinihon J Dermatol 1995 57:1206 1211. (in Japanese)
8. Yoshizawa Y, Kawana S. Efficacy of ebastine in the treatment of alopecia areata, Jpn J Dermatol 2005 115:1473 1480 (in Japanese).
9. Ashenager MS, Grgela T, Aragane Y, Kawada A. Inhibition of cytokine-induced expression of T-cell cytokines by antihistamines. J Investig Allergol Clin Immunol 2007 17:20 26.
10. Paolieri F, Battifora M, Riccio AM et al. Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. Ann Allergy Asthma Immunol 1998 81:601 607.
11. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 1992 89:1398 1402.
12. Hoffmann R, Wenzel E, Huth A et al. Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 1994 103:530 533.
13. Katagiri K, Arakawa S, Hatano Y, Fujiwara S. Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata. J Dermatol 2006 33:75 79.